On July 9, 2021, President Biden issued an executive order (EO) containing 72 directives to more than a dozen federal agencies, many of which have broad implications for healthcare. Specifically targeted are healthcare competition, hospital mergers,... Read More
Blogs & Articles | Healthcare | Healthcare Law | Hospitals and Healthcare Systems | In-house Counsel Legal Support Services | Life Sciences | Pharmaceutical Manufacturers | Pharmacy Law | Pharmacy Transactions | Physician Dispensing | Physicians and Medical Practices of all Specialties | Professional Practice Representation | Regulatory Compliance, including FDA, DEA and HIPAA

Frier Levitt Co-Founding Partner Daniel B. Frier recently summarized a variety of ways in which providers can become ensnarled in fraudulent schemes disguised as legitimate business models.  Since the publication of that article, a significant... Read More
Federal and State Fraud and Abuse Counseling | Healthcare | Hospitals and Healthcare Systems | In-house Counsel Legal Support Services | Professional Board Actions | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Defense and Government Investigation

In case you missed our webinar on Friday, June 19, 2020 on "Legal Issues and Guidelines Associated with Reopening Practices Post COVID-19" or want to watch it again to get any practice reopening tips you may have missed, we are pleased to share an... Read More
COVID-19 Resources | Healthcare | Healthcare Law | Healthcare Practice Compliance | Hospital/Physician Negotiations and Joint Ventures | Hospitals and Healthcare Systems | In-house Counsel Legal Support Services | Webinars